Haruhiko Inufusa

Short Bio:

Dr. Haruhiko Inufusa was born Okayama Japan at 1957. After finished Medical School Kindai University at 1982, he starts work at Surgery department of Kindai University Hospital. At the period of post graduate school of Kindai University, he started research of cancer especially on metastasis phenomenon. He established various cancer cell lines, and one cell line had potential of metastasis in nude mouse. He achieved principal graduation by this research result at 1988. During post doctor fellowship position 1988-1990 at University Washington Seattle, Professor Sen-itchiro Hakomori laboratory, cancer and glycolipid was main research target. Later, he found Lewis Y glycolipid of cancer controls blood coagulation and metastasis as well. At 2001, He promoted professor at Kindai University School of Medicine (Department of Surgery) and Faculty of Agriculture (Department of Clinical Nutrition). As surgent, he was one of first 15 doctors in Japan who started laparoscopic surgery for colorectal cancer, and his surgical video was widely used to educate young doctors. Resigned Director of Advanced Medical Technology and Medical Economics, at Kindai University School of Medicine at 2006. He starts research on alcohol, sugar, and fat metabolism at TIMA Japan Inc. which supported by TIMA foundation. After invention of anti-alcohol supplement SUPLAIV, he invented Twendee X that activate sugar and fat metabolisms. Strong anti-oxidant effects of Twendee X were found at 2011, he starts producing and marketing SUPAILV and Twendee X by the request of TIMA foundation. At 2013, Gifu university started his laboratory Division of Antioxidant Research. His present main intention is treatment of various patients with Twendee X. Geim International Innovation Award was granted to him at SIPS2018 meeting for his presentation.